Clinical Trials Logo

Keratitis, Herpetic clinical trials

View clinical trials related to Keratitis, Herpetic.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05720715 Recruiting - Clinical trials for Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis

Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis

Start date: January 1, 2022
Phase: Phase 4
Study type: Interventional

Objective: To compare the additive effect of topical cyclosporine A 0.05% eye drops to prednisolone eye drops, with topical prednisolone acetate 1% eye drops alone in treatment of herpetic stromal keratitis. Methods: Patients diagnosed with herpetic stromal keratitis are randomly divided into 2 groups; Group A: receive cyclosporine eye drops together with prednisolone eye drops. Group B: receive topical prednisolone with placebo eye drops (tear replacement). The 2 groups receive systemic acyclovir therapeutic dose 400 mg five times daily, which then tapered to twice daily prophylactic dose after one month of treatment. Follow up for patients is scheduled as a weekly visit for a duration of 2 months.

NCT ID: NCT03217474 Recruiting - Clinical trials for Herpes Simplex Keratitis

Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis

Start date: July 20, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to learn if adding femtosecond laser-assisted corneal debridement to a standard therapy of oral ganciclovir can help shorten the healing time of herpes simplex epithelial keratitis (HSK).

NCT ID: NCT03013959 Recruiting - Keratitis, Herpetic Clinical Trials

Observation on the Herpes Simplex Keratitis

OHSV
Start date: November 2016
Phase: N/A
Study type: Observational [Patient Registry]

As is reported, NSAIDs(pranoprofen ,bromfenac) eye drops can suppress herpes simplex virus(HSV-1) reactivation and reduce inflammatory reaction in vitro and in vivo. In Clinical, there is no risk of corneal tissue melting, glaucoma, cataract by topical application of NSAIDs. To explore more effective clinical treatment of viral keratitis patients to control the inflammatory damage, save the visual function and reduce the recurrence of the virus ,we observe the effect of anti-inflammatory and inhibition of recurrence on the herpes simplex virus after topical NSAIDs administration.

NCT ID: NCT02826174 Recruiting - Corneal Ulcer Clinical Trials

Topical Anesthesia for Closed PKP vs Retrobulbar Anesthesia for Open-sky PKP

Start date: December 2015
Phase: N/A
Study type: Interventional

Penetrating keratoplasty (PKP) is an open-sky surgery that fundamentally has not changed for more than 100 years. Because conventional PKP is associated with the potential for the development of devastating complications such as expulsive suprachoroidal hemorrhage and endophthalmitis, we modified the technique to one that is a closed surgery under topical anesthesia with the anterior chamber maintained to achieve favorable results. Topical anesthesia is an attractive alternative to traditional injection local anesthesia since the potentially serious complications associated with retrobulbar and peribulbar anesthesia can be avoided. The closed PKP procedure with the stable anterior chamber essentially changes the open nature of conventional PKP. The advantages, i.e., decreased surgical risks, postoperative complications, and surgical difficulties, make PKP viable in most complicated cases.